A Confluence of Risk: An Aboriginal Man, Diabetes, and an SGLT2 Inhibitor.

Fournier's gangrene is a rare, life-threatening disease that presents a substantial diagnostic challenge. The authors have presented a case of a patient with diabetes, sodium-glucose cotransporter 2 inhibitor use, and Aboriginal heritage, illustrating a unique confluence of risk. Clinical vigilance and the rapid mobilization of resources enabled secondary prevention through early antibiotic administration, surgical consultation, and diagnostic imaging. This strategy mitigated morbidity and mortality, facilitating a favorable clinical outcome. Emergency practitioners must recognize these converging risk factors to maintain high vigilance for this diagnostic challenge.